Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.

NCT02102165 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT02102165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02102165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
Lead sponsor
Jules Bordet Institute
Phase
Not applicable
Overall status
Recruiting
Start date
April 30, 2014
Completion date
March 31, 2031
Enrollment
1,000 (estimated)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer